
General Orthopaedics
Mesenchymal stem cell injections for knee OA demonstrate potential benefit
Int Orthop. 2015 Dec;39(12):2363-727 studies (6 RCTs and 1 CCT) that included a total of 314 patients with knee osteoarthritis (OA) were included in this meta-analysis and systematic review. The purpose of this review was to elucidate the efficacy of mesenchymal stem cell (MSC) injections in the treatment of knee OA by evaluating its effect on pain and function outcomes. While the findings of this study demonstrated potential efficacy for MSC injections for pain reduction and functional improvement that warrant further investigation, these findings were observed in a subgroup of higher quality studies or were associated with significant heterogeneity due to varying follow-up periods, doses of MSC and differing control groups. The low quality of evidence within the included trials limits the ability to draw conclusive results.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.